Nicole K Lee1, Richard A Rawson. 1. Clinical Research Program, Turning Point Alcohol and Drug Centre, Melbourne, Australia. nicole.lee@turningpoint.org.au
Abstract
INTRODUCTION AND AIMS: The use of methamphetamine is widespread and poses significant challenges for treatment providers. Much of the treatment knowledge about this group has been extrapolated from studies of treatment for cocaine dependence. Medications have been shown to be of limited effectiveness for methamphetamine users, making psychological interventions the treatment of choice. APPROACH: This paper describes a systematic review of cognitive-behavioural and behavioural interventions for methamphetamine users. A systematic search of published literature was undertaken focusing only on randomised trials. KEY FINDINGS: There were a relatively small number of intervention studies that compared cognitive-behavioural or behavioural interventions using randomised trial methodology. Most commonly, studies examined cognitive-behaviour therapy (CBT) and/or contingency management (CM). Treatment with CBT appears to be associated with reductions in methamphetamine use and other positive changes, even over very short periods of treatment (two and four sessions). CM studies found a significant reduction of methamphetamine during application of the procedure, but it is not clear if these gains are sustained at post-treatment follow-up. IMPLICATIONS: The review highlights that there are effective treatments for methamphetamine dependence. Alcohol and other drug (AOD) clinicians are familiar with these types of interventions and should use them and convey to clients that they are effective. Services and policy makers should ensure that best practice interventions are implemented within AOD services. CONCLUSION: Psychological intervention is effective in addressing methamphetamine use and dependence. CBT and contingency management are two accessible interventions that are implemented easily within current AOD services. There is still more work to conduct in improving methamphetamine treatment, however, and further research into cognitive-behavioural and behavioural treatments for methamphetamine users is required, with a focus on improving longevity of the effect of intervention and improving effectiveness among more complex presentations.
INTRODUCTION AND AIMS: The use of methamphetamine is widespread and poses significant challenges for treatment providers. Much of the treatment knowledge about this group has been extrapolated from studies of treatment for cocaine dependence. Medications have been shown to be of limited effectiveness for methamphetamine users, making psychological interventions the treatment of choice. APPROACH: This paper describes a systematic review of cognitive-behavioural and behavioural interventions for methamphetamine users. A systematic search of published literature was undertaken focusing only on randomised trials. KEY FINDINGS: There were a relatively small number of intervention studies that compared cognitive-behavioural or behavioural interventions using randomised trial methodology. Most commonly, studies examined cognitive-behaviour therapy (CBT) and/or contingency management (CM). Treatment with CBT appears to be associated with reductions in methamphetamine use and other positive changes, even over very short periods of treatment (two and four sessions). CM studies found a significant reduction of methamphetamine during application of the procedure, but it is not clear if these gains are sustained at post-treatment follow-up. IMPLICATIONS: The review highlights that there are effective treatments for methamphetamine dependence. Alcohol and other drug (AOD) clinicians are familiar with these types of interventions and should use them and convey to clients that they are effective. Services and policy makers should ensure that best practice interventions are implemented within AOD services. CONCLUSION: Psychological intervention is effective in addressing methamphetamine use and dependence. CBT and contingency management are two accessible interventions that are implemented easily within current AOD services. There is still more work to conduct in improving methamphetamine treatment, however, and further research into cognitive-behavioural and behavioural treatments for methamphetamine users is required, with a focus on improving longevity of the effect of intervention and improving effectiveness among more complex presentations.
Authors: John M Roll; Nancy M Petry; Maxine L Stitzer; Mary L Brecht; Jessica M Peirce; Michael J McCann; Jack Blaine; Marilyn MacDonald; Joan DiMaria; Leroy Lucero; Scott Kellogg Journal: Am J Psychiatry Date: 2006-11 Impact factor: 18.112
Authors: Steven Shoptaw; Alice Huber; James Peck; Xiaowei Yang; Juanmei Liu; John Roll; Benjamin Shapiro; Erin Rotheram-Fuller; Walter Ling Journal: Drug Alcohol Depend Date: 2006-04-18 Impact factor: 4.492
Authors: Steven Shoptaw; Cathy J Reback; James A Peck; Xiaowei Yang; Erin Rotheram-Fuller; Sherry Larkins; Rosemary C Veniegas; Thomas E Freese; Christopher Hucks-Ortiz Journal: Drug Alcohol Depend Date: 2004-11-28 Impact factor: 4.492
Authors: Craig R Rush; William W Stoops; Joshua A Lile; Paul E A Glaser; Lon R Hays Journal: Psychopharmacology (Berl) Date: 2010-11-12 Impact factor: 4.530
Authors: Dara G Ghahremani; Golnaz Tabibnia; John Monterosso; Gerhard Hellemann; Russell A Poldrack; Edythe D London Journal: Neuropsychopharmacology Date: 2011-02-02 Impact factor: 7.853
Authors: Matthew J Mimiaga; Elizabeth F Closson; David W Pantalone; Steven A Safren; Jennifer A Mitty Journal: Psychol Health Med Date: 2018-09-13 Impact factor: 2.423
Authors: Justin T Gass; Megan P H Osborne; Noreen L Watson; Jordan L Brown; M Foster Olive Journal: Neuropsychopharmacology Date: 2008-09-17 Impact factor: 7.853
Authors: Karen F Corsi; Wayne E Lehman; Sung-Joon Min; Shannon P Lance; Nicole Speer; Robert E Booth; Steve Shoptaw Journal: J AIDS Clin Res Date: 2012-06-04
Authors: Andy C Dean; Edythe D London; Catherine A Sugar; Christina M R Kitchen; Aimee-Noelle Swanson; Keith G Heinzerling; Ari D Kalechstein; Steven Shoptaw Journal: Drug Alcohol Depend Date: 2009-07-15 Impact factor: 4.492